bosentan anhydrous has been researched along with canavanine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gedikoglu, G; Guc, MO; Iskit, AB; Sungur, A | 1 |
| Guc, MO; Iskit, AB | 1 |
2 other study(ies) available for bosentan anhydrous and canavanine
| Article | Year |
|---|---|
The effects of bosentan, aminoguanidine and L-canavanine on mesenteric blood flow, spleen and liver in endotoxaemic mice.
Topics: Animals; Antihypertensive Agents; Body Weight; Bosentan; Canavanine; Dose-Response Relationship, Drug; Drug Interactions; Endothelin Receptor Antagonists; Endotoxins; Guanidines; Liver; Mice; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Organ Size; Splanchnic Circulation; Spleen; Sulfonamides | 1999 |
The timing of endothelin and nitric oxide inhibition affects survival in a mice model of septic shock.
Topics: Animals; Antihypertensive Agents; Bosentan; Canavanine; Disease Models, Animal; Endothelin Receptor Antagonists; Endotoxins; Enzyme Inhibitors; Guanidines; Lipopolysaccharides; Male; Mice; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Shock, Septic; Sulfonamides; Survival Rate | 2001 |